147 related articles for article (PubMed ID: 34505521)
1. The cell body space occupied by the nucleus during the cell differentiation in human lymphocytic, granulocytic and erythroid cell lineages.
Smetana K; Klamová H; Mikulenková D; Čermák J; Otevřelová P; Karban J; Trněný M
Physiol Res; 2021 Nov; 70(5):701-707. PubMed ID: 34505521
[TBL] [Abstract][Full Text] [Related]
2. The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note).
Smetana K; Klamová H; Mikulenková D; Karban J; Trněný M
Physiol Res; 2023 Aug; 72(4):521-524. PubMed ID: 37795894
[TBL] [Abstract][Full Text] [Related]
3. To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient model.
Smetana K; Klamová H; Mikulenková D
Physiol Res; 2019 Aug; 68(4):633-638. PubMed ID: 31177792
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
5. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
6. Morphometric and Densitometric Analysis of Heterochromatin during Cell Differentiation Using the Leukaemic Granulocytic Lineage as a Convenient Model.
Smetana K; Mikulenková D; Klamová H
Folia Biol (Praha); 2017; 63(1):1-5. PubMed ID: 28374668
[TBL] [Abstract][Full Text] [Related]
7. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Viswanathan K; Roboz G; Chadburn A; Mathew S
Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
[TBL] [Abstract][Full Text] [Related]
8. Heterochromatin density (condensation) during cell differentiation and maturation using the human granulocytic lineage of chronic myeloid leukaemia as a convenient model.
Smetana K; Mikulenková D; Klamová H
Folia Biol (Praha); 2011; 57(5):216-21. PubMed ID: 22123464
[TBL] [Abstract][Full Text] [Related]
9. To the Nuclear Region Occupied by Nucleolar Bodies in Human Leukaemic Myeloblasts of Kasumi 1 and K 562 Lineages.
Smetana K; Otevřelová P; Kuželová K; Zápotocký M
Folia Biol (Praha); 2018; 64(5-6):182-185. PubMed ID: 30938675
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
Bhattacharyya PK
Indian J Pathol Microbiol; 2013; 56(3):188-9. PubMed ID: 24152491
[TBL] [Abstract][Full Text] [Related]
11. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
12. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia associated with myelodysplastic syndrome and/or chronic myeloid leukemia: evidence for independent clonal chromosomal evolution.
Mossafa H; Fourcade C; Pulic M; Jary L; Cheze S; Szpiro-Tapia S; Troussard X
Leuk Lymphoma; 2001 Apr; 41(3-4):337-41. PubMed ID: 11378546
[TBL] [Abstract][Full Text] [Related]
14. CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells.
Huang SY; Liu YH; Chen YJ; Yeh YY; Huang HM
J Cell Physiol; 2018 Sep; 233(9):7467-7479. PubMed ID: 29663362
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P
Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649
[TBL] [Abstract][Full Text] [Related]
16. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
[TBL] [Abstract][Full Text] [Related]
17. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
18. Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.
Yang Y; Liu X; Xiao F; Xue S; Xu Q; Yin Y; Sun H; Xu J; Wang H; Zhang Q; Wang H; Wang L
PLoS One; 2015; 10(2):e0117573. PubMed ID: 25688862
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous occurrence of chronic lymphocytic and chronic myeloid leukemia.
Katović SK; Vasilj A; Maricević I; Carzavec D; Jurić SC
Coll Antropol; 2010 Jun; 34(2):653-5. PubMed ID: 20698147
[TBL] [Abstract][Full Text] [Related]
20. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
